孙海波
Date of Birth:1981-05-24
Gender:Male
Education Level:With Certificate of Graduation for Doctorate Study
Alma Mater:南京医科大学
Paper Publications
-
Aneeqa Majeed, Ali Afzal, Yajun Wang, Muhammad Babar Khawar, Kabeer Haneef, Haibo Sun: Mini-Organs with Big Impact: Organoids in Liver Cancer Studies.Oncology Research,2023,
-
Muhammad Babar Khawar1,2,3†, Fei Ge4†, Ali Afzal1,2† and Haibo Sun1,2*From Barriers to Novel Strategies: Smarter CAR T Therapy Hits Hard to Tumors.Frontiers in Immunology,2023,
-
高宇;陈海玲;王心悦;戴志晨;余诗奕;孙海舰;孙海波. 乳腺癌新辅助化疗联合免疫治疗的临床研究进展.肿瘤,2023,
-
Integrative analyses of bulk microarray data to discover genes, pathways, and immune infiltration characteristics associated with targeting of Ewing sarcoma.Journal of Cancer Research and Clinical Oncology,2023,
-
Shiyi Yu 1,2, Zhengyan Liang 1,2, Zhehao Fan 1,2, Binjie Cao 1,2, Ning Wang 1,2, Rui Wu 1,2 and Haibo Sun 1,2.A Comprehensive Analysis Revealing FBXW9 as a Potential Prognostic and Immunological Biomarker in Breast Cancer.[SCI].International Journal of Molecular Science,2023,
-
Dan Lv 1 2 3 , Muhammad Babar Khawar 1 3 4 , Zhengyan Liang 1 3 , Yu Gao 1 3 , Haibo Sun.Neoantigens and NK Cells: "Trick or Treat" the Cancers?.[Research Review].Frontiers in Immunology,2022,
-
CAR-NK Cells: From Natural Basis to Design for Kill.[SCI].Frontiers in Immunology,2021,
-
Ultrasound, computed tomography, magnetic resonance, and gamma scintigraphy-based detection and bio-imaging technologies have achieved outstanding breakthroughs in recent years. However, these technologies still encounter several limitations such as insufficient sensitivity, specificity and security that limit their applications in cancer detection and bio-imaging. The semiconductor quantum dots (QDs) are a kind of newly developed fluorescent nanoparticles that have superior fluorescence intensi.[SCI].Frontiers in Oncology,2021,
-
Haibo Sun,Tomas G. Martin,Jeffrey L. Wolf,Jeffrey M. Venstrom,Marielle Chiron,Sandrine Macé,Jonathon Keats,Denice Kong,John Marra.Individualized genetic makeup that controls natural killer cell function influences the efficacy of Isatuximab immunotherapy in patients with multiple myeloma.[journalArticle].Journal for ImmunoTherapy of Cancer,2021,